MedPath

Cross-Sectional Survey on the Use of Tobacco Products - Germany

Terminated
Conditions
Tobacco Use
Interventions
Other: Survey on Use of Tobacco Products in IQOS Users
Other: Survey on Use of Tobacco Products in the General Population
Registration Number
NCT03527017
Lead Sponsor
Philip Morris Products S.A.
Brief Summary

The main purpose of the research study is to estimate the prevalence of tobacco product use and describe the tobacco use patterns in adults in Germany.

Detailed Description

The aim of the survey is to describe the current and past patterns of use of tobacco products in the general adult population of Germany and in adult IQOS users registered in the IQOS user database of Philip Morris GmbH (Germany IQOS User Database), and explore their association with key independent variables. More specifically, the objectives are:

1. Estimate the prevalence of current tobacco use status in the study population.

2. Describe the past tobacco use status (cigarette, IQOS and other innovative products, including e-cigarettes) in the study population (i.e. never-use, initiation, product use transition, cessation, re-initiation, and relapse).

3. Explore the association between self-reported health status and use of tobacco products in the study population.

4. Explore the association between patterns of use (including misuse) with motivation to use, perceived quality attributes of IQOS (e.g. risk and self-reported changes since switching to the product, in a number of relevant domains where IQOS may have potential benefits), and consumer's satisfaction in the population of IQOS users in Germany registered in the Germany IQOS User Database.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
6284
Inclusion Criteria

Not provided

Exclusion Criteria
  • Not meeting the inclusion criteria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
IQOS UsersSurvey on Use of Tobacco Products in IQOS UsersAdult current IQOS users (at the time of survey) living in Germany who are registered in the Germany IQOS User Database and agreed to be contacted for research purposes at the time of registration.
General PopulationSurvey on Use of Tobacco Products in the General PopulationAdults living in Germany.
Primary Outcome Measures
NameTimeMethod
Self-reported health statusStudy duration (3 years).

Association between self-reported health status and use of tobacco products in the study population.

IQOS use experienceStudy duration (3 years).

Describe the IQOS user experience, including motivation to use, mis-use, satisfaction, and self-reported changes since switching to the product (in a number of domains where IQOS may have potential benefits).

Perceived riskStudy duration (3 years).

Association between patterns of use with perceived risk.

Prevalence of current tobacco useStudy duration (3 years).

Prevalence of current tobacco use status in the study population.

Past tobacco use statusStudy duration (3 years).

Past tobacco use status (cigarette, IQOS and other innovative products) in the study population.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Philip Morris Products S.A.

🇨🇭

Lausanne, Vaud, Switzerland

© Copyright 2025. All Rights Reserved by MedPath